Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

Placental malaria vaccines (PMVs) are being developed to prevent severe sequelae of placental malaria (PM) in pregnant women and their offspring. The leading candidate vaccine antigen VAR2CSA mediates parasite binding to placental receptor chondroitin sulfate A (CSA). Despite promising results in sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Doritchamou, Justin, Nielsen, Morten A., Chêne, Arnaud, Viebig, Nicola K., Lambert, Lynn E., Sander, Adam F., Semblat, Jean-Philippe, Hundt, Sophia, Orr-Gonzalez, Sachy, Janitzek, Christoph Mikkel, Spiegel, Alicia J., Clemmensen, Stine B., Thomas, Marvin L., Nason, Martha C., Snow-Smith, Maryonne, Barnafo, Emma K., Shiloach, Joseph, Chen, Beth B., Nadakal, Steven, Highsmith, Kendrick, Ouahes, Tarik, Conteh, Solomon, Sharma, Ankur, Torano, Holly, Butler, Brandi, Reiter, Karine, Rausch, Kelly M., Scaria, Puthupparampil V., Anderson, Charles, Narum, David L., Salanti, Ali, Fried, Michal, Theander, Thor G., Gamain, Benoit, Duffy, Patrick E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689237/
https://www.ncbi.nlm.nih.gov/pubmed/37932470
http://dx.doi.org/10.1038/s41684-023-01274-2

Ejemplares similares

Ejemplares similares